The Guidelines for Risk Assessment of Drug Production Site Inspection was issued on May.13, 2014. It aims to further strengthen the supervision and administration of drug production, standardize and guide the on-site inspection work, and unify the inspection and evaluation standards, which includes relevant guidelines.
- Local Title:药品生产现场检查风险评定指导原则
- Country/Region:Chinese Mainland
- Competent Authority: Former China Food and Drug Administration (CFDA)
- Type:Guideline
- Status:In force
- Release Date:2014-05-13
- Implementation Date:2014-05-13